Facebook
Twitter
LinkedIn

Media Center

Introducing Fall 2019 FAST Companies
Facebook
Twitter
LinkedIn

Four life science startups, vetted and selected by a distinguished review panel, will join CLSI’s Fall 2019 Fellows All-Star Team (FAST) Advisory Program. The Fall 2019 FAST cohort includes:

  • Algen Biotechnologies – Algen is a therapeutic discovery company, building an intelligent platform to decode functional gene networks for drug discovery.
  • Altay Therapeutics – Altay Therapeutics is developing a novel small molecule inhibitor for fibrosis, which targets a cellular protein that regulates matrix deposition and immune activation.
  • Convalesce – Convalesce is developing a peptide-based hydrogel matrix to transplant stem cells in the brain.
  • Reservoir Neuroscience – Reservoir Neuroscience is focused on repairing dysfunctional blood vessels in the brain — a previously unknown, and untreated, cause of cognitive dysfunction in aging, Alzheimer’s disease, and other neurological disorders.

Each company founder will be paired with a team of 10 to 12 advisors who will meet with them over 12 weeks in group advisory sessions. These meetings culminate in a final FAST Showcase on December 10 to a broad audience of industry professionals, entrepreneurs and potential investors.

Now starting its seventh year, FAST was developed to help some of the most innovative young life science companies FAST-track their way to funding and success. FAST’s 65 company graduates have received over 7000 volunteer advisory hours valued at over $1,500,000, have collectively raised over $880 million and have tripled their workforce, creating 364 new jobs since their participation in FAST.